To get more time between doses, high factor levels, and powerful protection from bleeds, more people choose IDELVION when switching their Factor IX (FIX) therapies.
By sticking to his prophylaxis regimen and physical therapy, Tony felt great about his recovery from surgery.
As a police officer, John can focus on the task at hand.
Now Ray is treating every 14 days to prevent bleeds rather than infusing to resolve them.
Milinda now spends less time driving to the hospital and more time with her family.
*Hemophilia FIX Market Assessment, Third-Party Market Research.
IDELVION delivered a zero median
annualized spontaneous bleeding rate
when dosed at 7 or 14 days in clinical trials
Keep up with the latest on
IDELVION info and news